Exploring Novel Frontiers in Cancer Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exploring Novel Frontiers in Cancer Therapy

Published:2024-06-18 Issue:6 Volume:12 Page:1345
ISSN:2227-9059
Container-title:Biomedicines
language:en
Short-container-title:Biomedicines

Author:

Tigu Adrian Bogdan¹^ORCID,Tomuleasa Ciprian¹²³^ORCID

Affiliation:

1. Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania

2. Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania

3. Department of Hematology, Ion Chiricuta Clinical Cancer Center, 400015 Cluj-Napoca, Romania

Abstract

Cancer progression and initiation are sustained by a series of alterations in molecular pathways because of genetic errors, external stimuli and other factors, which lead to an abnormal cellular function that can be translated into uncontrolled cell growth and metastasis [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/2227-9059/12/6/1345/pdf

Reference25 articles.

1. Hallmarks of Cancer: New Dimensions;Hanahan;Cancer Discov.,2022

2. Seoane, J., and Gomis, R.R. (2017). TGF-beta Family Signaling in Tumor Suppression and Cancer Progression. Cold Spring Harb. Perspect. Biol., 9.

3. Inhibition of transforming growth factor-β signals suppresses tumor formation by regulation of tumor microenvironment networks;Tokizaki;Cancer Sci.,2024

4. Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance;Xelwa;Front. Oncol.,2021

5. The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs;SDiepstraten;Nat. Rev. Cancer,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP